Lowe Brockenbrough & Co’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$11M Sell
91,627
-648
-0.7% -$74.8K 0.55% 48
2025
Q4
$9.71M Sell
92,275
-2,427
-3% -$228K 0.48% 55
2025
Q3
$7.95M Buy
94,702
+2,485
+3% +$205K 0.41% 62
2025
Q2
$7.3M Sell
92,217
-795
-0.9% -$63.2K 0.41% 64
2025
Q1
$8.42M Buy
93,012
+3,607
+4% +$337K 0.55% 57
2024
Q4
$8.97M Sell
89,405
-2,470
-3% -$255K 0.58% 56
2024
Q3
$10.5M Sell
91,875
-10,077
-10% -$1.2M 0.67% 48
2024
Q2
$12.7M Sell
101,952
-709
-0.7% -$91.3K 0.84% 37
2024
Q1
$13.6M Buy
102,661
+10,976
+12% +$1.35M 0.92% 35
2023
Q4
$10.1M Sell
91,685
-11,051
-11% -$1.15M 0.78% 41
2023
Q3
$10.6M Buy
102,736
+585
+0.6% +$63.1K 0.83% 37
2023
Q2
$11.8M Buy
102,151
+639
+0.6% +$72.6K 0.89% 33
2023
Q1
$10.9M Sell
101,512
-927
-0.9% -$100K 0.88% 34
2022
Q4
$11.4M Sell
102,439
-1,966
-2% -$201K 0.99% 30
2022
Q3
$9.05M Sell
104,405
-37,748
-27% -$3.37M 0.87% 36
2022
Q2
$13M Buy
142,153
+111
+0.1% +$9.84K 1.14% 22
2022
Q1
$11.7M Sell
142,042
-2,590
-2% -$204K 0.87% 35
2021
Q4
$11.2M Buy
144,632
+184
+0.1% +$14.7K 0.81% 42
2021
Q3
$10.9M Buy
144,448
+1,667
+1% +$127K 0.85% 39
2021
Q2
$11.1M Sell
142,781
-3,356
-2% -$250K 1% 35
2021
Q1
$10.8M Buy
146,137
+5,216
+4% +$385K 1.04% 31
2020
Q4
$11M Buy
140,921
+3,592
+3% +$275K 1.19% 23
2020
Q3
$10.9M Sell
137,329
-733
-0.5% -$57.4K 1.35% 15
2020
Q2
$10.2M Buy
138,062
+967
+0.7% +$72.8K 1.37% 17
2020
Q1
$10.1M Buy
137,095
+476
+0.3% +$37.4K 1.66% 14
2019
Q4
$11.9M Buy
136,619
+1,218
+0.9% +$100K 1.47% 15
2019
Q3
$10.9M Sell
135,401
-308
-0.2% -$24.7K 1.46% 15
2019
Q2
$10.9M Buy
135,709
+707
+0.5% +$54.1K 1.48% 14
2019
Q1
$10.7M Sell
135,002
-1,846
-1% -$138K 1.5% 15
2018
Q4
$9.98M Buy
136,848
+1,666
+1% +$118K 1.63% 14
2018
Q3
$9.15M Sell
135,182
-3,197
-2% -$204K 1.28% 21
2018
Q2
$8.02M Buy
138,379
+2,699
+2% +$152K 1.18% 24
2018
Q1
$7.05M Buy
135,680
+1,069
+0.8% +$57.7K 1.04% 29
2017
Q4
$7.23M Sell
134,611
-2,568
-2% -$142K 1.04% 30
2017
Q3
$8.38M Buy
137,179
+194
+0.1% +$11.8K 1.29% 22
2017
Q2
$8.38M Sell
136,985
-1,327
-1% -$80.8K 1.32% 23
2017
Q1
$8.39M Sell
138,312
-1,026
-0.7% -$62.2K 1.34% 22
2016
Q4
$7.83M Buy
139,338
+215
+0.2% +$12.6K 1.31% 22
2016
Q3
$8.29M Buy
139,123
+5,500
+4% +$322K 1.43% 17
2016
Q2
$7.34M Buy
133,623
+5,565
+4% +$296K 1.28% 23
2016
Q1
$6.46M Sell
128,058
-3,044
-2% -$149K 1.11% 27
2015
Q4
$6.61M Buy
131,102
+80,459
+159% +$4.06M 1.13% 28
2015
Q3
$2.39M Sell
50,643
-150
-0.3% -$7.97K 0.42% 78
2015
Q2
$2.76M Sell
50,793
-2,516
-5% -$141K 0.44% 77
2015
Q1
$2.92M Sell
53,309
-407
-0.8% -$23K 0.46% 75
2014
Q4
$2.91M Sell
53,716
-544
-1% -$30.3K 0.46% 79
2014
Q3
$3.07M Buy
54,260
+46
+0.1% +$2.58K 0.49% 72
2014
Q2
$2.99M Sell
54,214
-344
-0.6% -$18.8K 0.48% 71
2014
Q1
$2.96M Sell
54,558
-2,199
-4% -$114K 0.49% 74
2013
Q4
$2.71M Sell
56,757
-220
-0.4% -$10.1K 0.45% 73
2013
Q3
$2.59M Sell
56,977
-29,171
-34% -$1.33M 0.47% 71
2013
Q2
$3.82M Buy
+86,148
New +$3.85M 0.71% 56

Other funds holding MRK

Lowe Brockenbrough & Co's MRK Position: Q1 2026 in Review

Lowe Brockenbrough & Co reduced its Merck (MRK) stake by 0.7% in Q1 2026, selling an estimated $74.8K and leaving 91,627 shares worth $11M. The position accounts for 0.55% of the portfolio, ranked #48.

Lowe Brockenbrough & Co first reported a position in MRK in Q2 2013 and has held it in 52 quarters since. The position peaked at $13.6M in Q1 2024. 3,775 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Lowe Brockenbrough & Co held 91,627 shares of Merck worth $11M as of Q1 2026.
  • Lowe Brockenbrough & Co sold 648 Merck shares in Q1 2026, an estimated $74.8K.
  • Merck made up 0.55% of Lowe Brockenbrough & Co's portfolio in Q1 2026, its #48 holding.
  • Lowe Brockenbrough & Co first reported a position in Merck in Q2 2013 and has held it in 52 quarters since.
  • Lowe Brockenbrough & Co's Merck position peaked at $13.6M in Q1 2024.
  • 3,775 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Lowe Brockenbrough & Co's 13F filing for Q1 2026, filed 7 May 2026.